2 results
Approved WMOCompleted
The primary objective is to compare the efficacy of daratumumab when combined with lenalidomide and dexamethasone (DRd) to that of lenalidomide and dexamethasone (Rd), in terms of progression-free survival (PFS) in subjects with relapsed or…
Approved WMOPending
The objectives of this clinical investigation are:1. To demonstrate that the FIRE1* Sensor can be safely deployed into the inferior vena cava (IVC) 2. To demonstrate that the FIRE1* Sensor can provide a signal to the FIRE1* External System3. To…